Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Glucose

Subclass of:

600 - Surgery

600300000 - DIAGNOSTIC TESTING

600309000 - Measuring or detecting nonradioactive constituent of body liquid by means placed against or in body throughout test

600310000 - Infrared, visible light, or ultraviolet radiation directed on or through body or constituent released therefrom

Patent class list (only not empty are listed)

Deeper subclasses:

Entries
DocumentTitleDate
20110184260Methods and Apparatuses for Noninvasive Determinations of Analytes - The present invention provides methods and apparatuses for accurate noninvasive determination of tissue properties. Some embodiments of the present invention comprise an optical sampler having an illumination subsystem, adapted to communicate light having a first polarization to a tissue surface; a collection subsystem, adapted to collect light having a second polarization communicated from the tissue after interaction with the tissue; wherein the first polarization is different from the second polarization. The difference in the polarizations can discourage collection of light specularly reflected from the tissue surface, and can encourage preferential collection of light that has interacted with a desired depth of penetration or path length distribution in the tissue. The different polarizations can, as examples, be linear polarizations with an angle between, or elliptical polarizations of different handedness.07-28-2011
20130085352Controlling Transfer of Objects Affecting Optical Characteristics - An implantable product such as an article, device, or system can include analyte and non-analyte containers in parts that can be operated as optical cavities. The product can also include fluidic components such as filter assemblies that control transfer of objects that affect or shift spectrum features or characteristics such as by shifting transmission mode peaks or reflection mode valleys, shifting phase, reducing maxima or contrast, or increasing intermediate intensity width such as full width half maximum (FWHM). Analyte, e.g. glucose molecules, can be predominantly included in a set of objects that transfer more rapidly into the analyte container than other objects, and can have a negligible or zero rate of transfer into the non-analyte container; objects that transfer more rapidly into the non-analyte container can include objects smaller than the analyte or molecules of a set of selected types, including, e.g., sodium chloride. Output light from the containers accordingly includes information about analyte.04-04-2013
20100036216SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20130035567PHOTOLUMINESCENT NANOSTRUCTURE-BASED SENSORS - A composition for sensing an analyte can include a photoluminescent nanostructure complexed to a sensing polymer, where the sensing polymer includes an organic polymer non-covalently bound to the photoluminescent nanostructure and an analyte-binding protein covalently bound to the organic polymer, and where the analyte-binding protein is capable of selectively binding the analyte, and the analyte-binding protein undergoes a substantial conformational change when binding the analyte. Separately, a composition for sensing an analyte, can include a complex, where the complex includes a photoluminescent nanostructure in an aqueous surfactant dispersion and a boronic acid capable of selectively reacting with an analyte. The compositions can be used in devices and methods for sensing an analyte.02-07-2013
20100041969MEASURING DEVICE AND METHOD FOR OPTICALLY DETERMINING THE CONCENTRATION OF BLOOD SUGAR AND/OR LACTATE IN BIOLOGICAL SYSTEMS - The invention relates to a measuring device for optically determining the concentration of blood sugar and/or lactate in biological systems, comprising at least one IR radiation source, that radiates IR light on a volume that is to examined, and at least one measuring detector that detects light coming from the volume that is to be examined in order to determine the concentration of blood sugar and/or lactate, also by laymen in a simple manner and anywhere. According to the invention, the IR light radiated on the volume that is to be examined is supplied, prior to entry into the volume, to a reference detector.02-18-2010
20090156915Glucose Monitor and Method of Use Thereof - An apparatus for monitoring glucose comprising a processor, an indicating mechanism and sensors that are disposed proximate the skin of a person when the skin is in contact with a motor vehicle operational component such as the steering wheel. The apparatus for monitoring glucose measures the driver's glucose concentration via optical coherence tomography or other non-invasive technique, analyzes the driver's glucose concentration via the processor and displays the driver's glucose concentration via the indicator, or alternately sends an alarm signal. The method for monitoring glucose further comprises programming the processor with a range of glucose concentrations, comparing the driver's glucose concentration with the range and signaling an alert if the driver's glucose concentration is outside the range.06-18-2009
20130041237LIVING BODY INFORMATION MEASURING APPARATUS - A living body information measuring apparatus includes an optical system for irradiating light to a subject and detecting light from the subject, a signal processing portion for acquiring information with regard to a tissue condition of the subject based on a detecting signal of light, and a position determining portion for determining an acceptability of an irradiating position of light based on the detecting signal of light.02-14-2013
20130090537BLOOD GLUCOSE SENSOR - A method to measure glucose within the blood of a tissue test area includes illuminating the tissue test area using a single mode light source at a point of incidence, with at least some of the light penetrating tissue at the point of incidence; calibrating the light source by adjusting a distance between the point of incidence and an axicon lens; collecting returning radiation from the tissue test area at a point offset from the point of incidence; removing tissue fluorescence using edge filters; removing additional tissue fluorescence by shifting the excitation wavelength of the single mode light source; heating the test area; and analyzing a returned Raman signal to determine the glucose within the blood.04-11-2013
20130090536ANALYTE SENSOR METHOD AND APPARATUS - Provided herein are systems, methods, and apparatuses for an analyte sensor. In one aspect, an analyte sensing device comprises a sensor body member including at least one nanopore and an optical conduit in optical communication with the sensor body member. The optical conduit transmits optical energy to the sensor body member and receives reflected optical energy back from the sensor body member. A photodetector is optically coupled to the optical conduit to determine an optical parameter from the reflected optical energy.04-11-2013
20130072768INTRAVASCULAR GLUCOSE SENSOR - A glucose sensor for intravascular measurement of glucose concentration wherein the sensor is arranged to measure glucose concentration by monitoring the lifetime of the fluorophore, the sensor comprising:—an indicator system comprising a receptor for selectively binding to glucose and a fluorophore associated with said receptor, wherein the fluorophore has a life-time of less than 100 ns;—a light source;—an optical fibre arranged to direct light from the light source onto the indicator system; —a detector arranged to receive fluorescent light emitted from the indicator system; and—a signal processor arranged to determine information related to a fluorescence lifetime of the fluorophore based on at least the output signal of the detector.03-21-2013
20110060199DETERMINATION OF BLOOD PUMP SYSTEM PERFORMANCE AND SAMPLE DILUTION USING A PROPERTY OF FLUID BEING TRANSPORTED - The use of an optical or other measurement in a blood access system enables the determination of a fluid sample appropriate for measurement on a real time basis. This information can be used to control the blood access system and related measurement processes. The determination can be based on, for example, at least one of: optical density, optical scatter, analyte level, temperature, the absolute level of any of the preceding, the stability of any of the preceding, the rate of change of any of the preceding, or the value of any of the preceding relative to another determination. The determination can be made using, for example, at least one of: electrochemical sensor, ion specific electrode, capacitance measurement, impedance measurement, inductance measurement, conductivity measurement, optical measurement, and ultrasound measurement. The present invention relates to determination of the quality of a biological sample in which determination of an analyte concentration is to be made, and various methods and apparatuses related thereto. An evaluation of sample quality can be made by monitoring the temporal changes in the sample properties or characteristics as the biological sample is procured or measured. The methods and apparatuses described herein can be used to evaluate the temporal characteristics of a sample during sample acquisition and/or during determination of the sample analyte or parameter of interest. The sample quality assurance methods and apparatuses described herein can thus be used to ensure that a valid sample has been procured by or presented to an instrument or measurement system for analyte determination, thereby preventing the measurement and reporting of analyte values for a sample that is unstable or otherwise non-representative of the biological system from which the sample was obtained.03-10-2011
20130060107SUBCUTANEOUS GLUCOSE SENSOR - A glucose sensor for measurement of glucose in subcutaneous tissue, the sensor comprising: a probe for subcutaneous insertion, the probe containing an indicator system comprising a receptor for selectively binding to glucose and a fluorophore associated with said receptor, wherein the fluorophore has a fluorescence lifetime of less than 100 ns; a detector head which is optically connected to the probe and which is for location outside the body; a light source; and a detector arranged to receive fluorescent light emitted from the indicator system, wherein the light source and detector are optionally located within the detector head; wherein the sensor is arranged to measure glucose concentration in subcutaneous tissue by monitoring the fluorescence lifetime of the fluorophore.03-07-2013
20130060108METHOD FOR DATA REDUCTION AND CALIBRATION OF AN OCT-BASED PHYSIOLOGICAL MONITOR - The present invention relates to a method and system for estimating blood analyte levels using a noninvasive optical coherence tomography (OCT) based physiological monitor. An algorithm correlates OCT-based estimated blood analyte data with actual blood analyte data determined by other methods, such as invasively. OCT-based data is fit to the obtained blood analyte measurements to achieve the best correlation. Once the algorithm has generated sets of estimated blood analyte levels, it may refine the number of sets by applying one or more mathematical filters. The OCT-based physiological monitor can be calibrated using an Intensity Difference plot or the Pearson Product Moment Correlation method.03-07-2013
20130060105Orthogonally Redundant Sensor Systems and Methods - A continuous glucose monitoring system may include a hand-held monitor, a transmitter, an insulin pump, and an orthogonally redundant glucose sensor, which may comprise an optical glucose sensor and a non-optical glucose sensor. The former may be a fiber optical sensor, including a competitive glucose binding affinity assay with a glucose analog and a fluorophore-labeled glucose receptor, which is interrogated by an optical interrogating system, e.g., a stacked planar integrated optical system. The non-optical sensor may be an electrochemical sensor having a plurality of electrodes distributed along the length thereof. Proximal portions of the optical and electrochemical sensors may be housed inside the transmitter and operationally coupled with instrumentation for, e.g., receiving signals from the sensors, converting to respective glucose values, and communicating the glucose values. The sensors' distal portions may be inserted into a user's body via a single delivery needle and may be co-located inside the user's body.03-07-2013
20130060106OPTICAL SENSING SYSTEMS AND METHODS - An optical glucose sensor may include an optical fiber and a glucose-permeable membrane having a hollow interior and being coupled to the optical fiber's distal end. The membrane's hollow interior provides a compartment to house a competitive glucose binding affinity assay. The assay may include a glucose analog that may be labeled with a dye, and a glucose receptor that may be labeled with a fluorophore. The optical fiber may include a compound parabolic concentrator tip, and the compartment may additionally house a reflector disposed so as to face the optical fiber's tip. A fluorophore-labeled assay may be interrogated by an optical interrogating system including a light source and a filter substrate having one or more coatings to effect, e.g., an excitation filter and/or an emission filter. The interrogating system may be manufactured as a stacked planar integrated optical system and diced into smaller units.03-07-2013
20090270701DEVICE FOR MEASURING CONCENTRATION OF CONSTITUENT IN BLOOD ANDMEASURING METHOD - A device for measuring concentration of a constituent in blood includes: an irradiation unit for irradiating light toward a living body, the light having a wavelength disposed in a light absorption band of the constituent in the blood; a light receiving unit for receiving light, which is reflected in the living body or transmitted through the living body; and a concentration measurement unit for measuring the concentration of the constituent in the blood based on variation of light intensity of light received by the light receiving unit, the variation attributed to a pulse wave of the living body.10-29-2009
20090270700NON-INVASIVE GLUCOSE SENSOR - Apparatus and method for sensing HO activity, and in particular blood glucose level based on an analyte level determination, the analyte being carboxyhemoglobin. In a preferred embodiment, HO activity and/or blood glucose level are extrapolated from Hb-CO level by determining an intermediate CO level. The apparatus and method are preferably non invasive.10-29-2009
20090264719SENSOR FOR PERCUTANEOUS INTRAVASCULAR DEPLOYMENT WITHOUT AN INDWELLING CANNULA - The present invention relates to a sensor for percutaneous insertion and intravascular residence without an indwelling cannula. In preferred embodiments, a glucose sensor is inserted into a blood vessel using a removable cannula. After the cannula is removed, the glucose sensor remains within the blood vessel by itself and forms a seal with the patient's tissue.10-22-2009
20110021891NON-INVASIVE GLUCOSE MONITOR - In a non-invasive glucose monitor is configured to, by using a heat conductive member having a body surface contacting part for contacting a surface of a human body at its one end, measures a first temperature adjacent to the body surface contacting part and a second temperature adjacent to the other end apart from the body surface. The computing device takes in data of the first and second temperature, environmental temperature, radiation heat from the body surface, reflection light caused by reflecting the light of the two different wavelength at the body surface contacting part. The computing device stores a relationship between parameters and blood glucose levels in advance, thereby converts the above-mentioned data to parameters, and calculates a blood glucose level by applying the parameters to the relationship.01-27-2011
20120116191USE OF AN EQUILIBRIUM INTRAVASCULAR SENSOR TO ACHIEVE TIGHT GLYCEMIC CONTROL - A method for achieving tight glycemic control in a patient in need thereof is disclosed. The method comprises deploying an equilibrium glucose sensor within a blood vessel in the patient, coupling the sensor to a monitor that displays the blood glucose concentration, and administering a blood glucose regulator when the blood glucose concentration varies outside of the predetermined concentration range. The blood glucose regulator is administered in an amount sufficient to return the blood glucose concentration to within the predetermined concentration range, thereby achieving tight glycemic control.05-10-2012
20120238843OPTICAL BLOOD GLUCOSE DETECTING APPARATUS AND OPERATING METHOD THEREOF - An optical blood glucose detecting apparatus and an operating method thereof are disclosed. The optical blood glucose detecting apparatus includes a detecting module, an assisting and strengthening module, and a data processing module. The detecting module provides an incident optical signal passing through a detected portion of skin surface into a skin interstitial fluid, captures a blood glucose optical reflection message of the skin interstitial fluid, and it interferes the blood glucose optical reflection message and the incident optical signal to generate a detected data. The assisting and strengthening module provides a physical or chemical effect on a tissue region under the detected portion to strengthen the blood glucose optical reflection message. The data processing module processes the detected data to determine a blood glucose concentration.09-20-2012
20120238842INTEGRATED CATALYTIC PROTECTION OF OXIDATION SENSITIVE MATERIALS - An implantable device with in vivo functionality, where the functionality of the device is negatively affected by ROS typically associated with inflammation reaction as well as chronic foreign body response as a result of tissue injury, is at least partially surrounded by a protective material, structure, and/or a coating that prevents damage to the device from any inflammation reactions. The protective material, structure, and/or coating is a biocompatible metal, preferably silver, platinum, palladium, gold, manganese, or alloys or oxides thereof that decomposes reactive oxygen species (ROS), such as hydrogen peroxide, and prevents ROS from oxidizing molecules on the surface of or within the device. The protective material, structure, and/or coating thereby prevents ROS from degrading the in vivo functionality of the implantable device.09-20-2012
20120123230ANALYTE MONITORING SYSTEMS AND METHODS OF USE - Analyte monitoring systems and methods that make interstitial fluid from a patient's body available to one or more sensors disposed outside the patient's body. The monitoring systems and methods may be used in conjunction with medicament dispensing systems and methods in order to provide a feedback loop for continuous sensing of analyte levels and corresponding dispensing of medicament based on sensed analyte levels. Dispensing or pumping systems or portions thereof may be used to move a patient's interstitial fluid into communication with the one or more sensors.05-17-2012
20080214912Blood Glucose Monitoring System And Method - An optrode for insertion into a blood vessel can include at least one fiber optic, a sheath enclosing at least part of the fiber optic and sensor material in optical communication with one end of the fiber optic. The sensor material is operative for diffracting electromagnetic waves received from the fiber optic and is responsive to changes in an amount of glucose in contact therewith for changing a diffraction of the electromagnetic waves as a function thereof. A membrane covering a distal end of the sheath passes to the sensor material glucose from blood in contact with the side of the membrane opposite the sensor material. Electromagnetic waves input into the fiber optic cable are diffracted by the sensor material. A concentration of glucose in the blood can be estimated from the amount of diffraction of the electromagnetic waves. A signal can be output related to the estimated glucose concentration.09-04-2008
20080200782Health Monitoring Device, Device Modules and Method - The present invention relates to a health monitoring device for measuring blood or tissue indicators and a strip cassette suitable for use in connection with the device. The device comprises a body (08-21-2008
20120238841Sample capture in one step for test strips - A test strip is provided with sample capture that provides for a one step process to achieve a lancing event, sample capture and sample transport in a sensor design that supports one step testing. In various embodiments, the present invention provides for one step testing by, (i) analyte sample capture layout; (ii) analyte sample capture and transport configurations; (iii) structures of sample capture; (iv) processes for forming sample transport, and the like.09-20-2012
20100113900Multispot Monitoring for Use in Optical Coherence Tomography - Optical coherence tomography (herein “OCT”) based analyte monitoring systems are disclosed. In one aspect, techniques are disclosed that can identify fluid flow in vivo (e.g., blood flow), which can act as a metric for gauging the extent of blood perfusion in tissue. For instance, if OCT is to be used to estimate the level of an analyte (e.g., glucose) in tissue, a measure of the extent of blood flow can potentially indicate the presence of an analyte correlating region, which would be suitable for analyte level estimation with OCT. Another aspect is related to systems and methods for scanning multiple regions. An optical beam is moved across the surface of the tissue in two distinct manners. The first can be a coarse scan, moving the beam to provide distinct scanning positions on the skin. The second can be a fine scan where the beam is applied for more detailed analysis.05-06-2010
20090054750Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management - Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.02-26-2009
20080281171ANALYTE MONITORING SYSTEM AND METHODS - Methods and systems for providing data communication in medical systems are disclosed.11-13-2008
20120035442PORTABLE RAMAN DIAGNOSTIC SYSTEM - The present invention further relates to the selection of the specific filter combinations, which can provide sufficient information for multivariate calibration to extract accurate analyte concentrations in complex biological systems. The present invention also describes wavelength interval selection methods that give rise to the miniaturized designs. Finally, this invention presents a plurality of wavelength selection methods and miniaturized spectroscopic apparatus designs and the necessary tools to map from one domain (wavelength selection) to the other (design parameters). Such selection of informative spectral bands has a broad scope in miniaturizing any clinical diagnostic instruments which employ Raman spectroscopy in particular and other spectroscopic techniques in general.02-09-2012
20090221886METHOD AND APPARATUS FOR MEASURING ANALYTES - A method for measuring the concentration of various analytes in the blood of a part of a subject is provided An invasive or non-invasive sample of blood may be used for this determination Also provided is a device for measuring the concentration of a compound in the blood of a subject. The device comprises a source of electromagnetic radiation, a holder, a detector and a processing system.09-03-2009
20090054746Device for channeling fluid and methods of use - Method and apparatus for channeling fluid away from an insertion site having a channel guiding the fluid flow from the insertion site, and a channeling compartment containing absorbent material to wick the fluid such as blood away from the insertion site is provided.02-26-2009
20080269575Method and Apparatus for Monitoring Bodily Analytes - The present invention relates mainly to a method and apparatus for monitoring bodily analytes, such as glucose, by use of an analyzer (10-30-2008
20100099960Device and method for measuring a property of living tissue - A device for measuring the glucose level in living tissue has electrodes (04-22-2010
20090088614On-body medical device securement - Devices and methods for maintaining a medical device on-body are provided. Embodiments include medical device securement systems having first and second on-body securement elements. Also provided are systems and kits for use maintaining a medical device on-body.04-02-2009
20090292186Method and System for Non-Invasive Optical Blood Glucose Detection Utilizing Spectral Data Analysis - Systems and methods are disclosed for non-invasively measuring blood glucose levels in a biological sample based on spectral data. A variety of techniques are disclosed for improving signal-to-noise ratio in the acquisition of spectral data and calculating attenuance of light attributable to blood in a sample. Disclosed techniques include (1) using a standard deviation operation in conjunction with the logarithm function, (2) using a normalization factor, (3) using a ratio factor, (4) accounting for the effect of temperature on various system components such as resistors, and (5) accounting for dark current in a light detector by performing a calibration.11-26-2009
20090275814SYSTEM AND METHOD FOR MEASURING CONSTITUENT CONCENTRATION - A system and method for measuring concentration of a constituent of a specimen are provided. The system includes an oscillator for outputting, towards the specimen, electromagnetic waves having respective different frequencies between 5 GHz and 300 GHz; a detector for detecting the electromagnetic waves that are reflected from the specimen; and a processor measuring at least one of reflection coefficient and complex permittivity of the electromagnetic waves detected and calculating the concentration of the constituent of the specimen based upon at least one of the reflection coefficient measured and the complex permittivity measured.11-05-2009
20080275318BIOSENSORS FOR MEASURING ANALYTES IN THE INTERSTITIAL FLUID - The invention relates to methods and devices for measuring blood glucose levels in a subject, where the methods and devices are designed for exposing a sensing mechanism to interstitial fluid in the subject.11-06-2008
20080275319Non-Invasive System and Method for Measuring Skin Hydration of a Subject - A non-invasive system and method for measuring skin hydration of a subject comprising a thermistor (11-06-2008
20130217983ANALYTE SENSOR - Embodiments provide analyte sensors, such as implantable analyte sensors, and methods of producing the same. An implantable sensor may include a base with a plurality of chambers. One or more sensor reagents may be retained within the chambers to form analysis regions. A membrane may be coupled to the chambers over the sensor reagents. The implantable sensor may be implanted into the dermis of a subject. One or more of the sensor reagents may exhibit a color change in response to the presence of a target analyte or reaction product thereof. The wavelengths of light reflected from the analysis regions may be detected and analyzed to determine a target analyte concentration. One or more portions of the sensor or components thereof may be configured to facilitate calibration of the sensor, correction of an optical signal obtained from the sensor by a reader device to accommodate variations in the surrounding tissues, and/or calculation of a representative value by a reader device.08-22-2013
20090030295INSTRUMENT FOR MEASURING CONCENTRATION OF LIVING BODY INGREDIENT - A biological constituent concentration measuring device that can measure a biological constituent concentration highly accurately using a radiation that has come from an eardrum is provided.01-29-2009
20090054749Method and System for Providing Data Transmission in a Data Management System - Methods and apparatuses for providing a data transmission unit antenna for wireless data transmission in a data monitoring and management system are provided.02-26-2009
20090054747Method and system for providing analyte sensor tester isolation - Method and apparatus for providing electrical isolation between devices in batch testing process during manufacturing procedure is provided.02-26-2009
20090036760METHOD AND APPARATUS FOR PROVIDING DATA PROCESSING AND CONTROL IN A MEDICAL COMMUNICATION SYSTEM - Methods and apparatus for providing data processing and control for use in a medical communication system are provided.02-05-2009
20090062632Non-Invasive System and Method for Measuring an Analyte in the Body - A system for determining an analyte concentration in a fluid sample (e.g., glucose) comprises a light source, a detector, and a central processing unit. The detector is adapted to receive spectral information corresponding to light returned from the fluid sample being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid. The algorithm is adapted to convert the received spectral information into the analyte concentration in body fluid. Spectral information is delivered from the central processing unit to the light source and used to vary the intensity and timing of the light to improve the accuracy of conversion into analyte concentration.03-05-2009
20090209834System and Method for In Vivo Measurement of Biological Parameters - A system, method and medical tool are presented for use in non-invasive in vivo determination of at least one desired parameter or condition of a subject having a scattering medium in a target region. The measurement system comprises an illuminating system, a detection system, and a control system. The illumination system comprises at least one light source configured for generating partially or entirely coherent light to be applied to the target region to cause a light response signal from the illuminated region. The detection system comprises at least one light detection unit configured for detecting time-dependent fluctuations of the intensity of the light response and generating data indicative of a dynamic light scattering (DLS) measurement. The control system is configured and operable to receive and analyze the data indicative of the DLS measurement to determine the at least one desired parameter or condition, and generate output data indicative thereof.08-20-2009
20090247842Interferometric Measuring Instrument for Taking Optical Measurements on Skin Structures - An interferometric measuring instrument for taking optical measurements on skin structures, having a beam splitter for splitting an input beam, emitted by a light source, into an object beam and a reference beam; having an object branch via which the object beam is directed to the skin, and the object beam, scattered back from the skin structures, is returned; having a reference branch via which the reference beam is directed to a reference and returned from it; and having a detector device for picking up the recombined and interfering radiation of the back-scatted object beam and of the returned reference beam and for evaluating the intensity modulation obtained due to the interference. The following measures contribute significantly to a reliable and rapid optical measurement, e.g., of the blood-sugar concentration: In order to scatter back a portion of the object beam directed into the skin, an implant having a front side facing the incident object beam and a back side facing away from it is introduced into the skin, the implant having a refractive index different from the surrounding skin substance.10-01-2009
20090253970SYSTEM FOR OPTIMIZING A PATIENT'S INSULIN DOSAGE REGIMEN - A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.10-08-2009
20130123590Constituent Concentration Measuring Apparatus and Constituent Concentration Measuring Apparatus Controlling Method - An object of the present invention is to provide a noninvasive constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method, in which accurate measurement can be performed by superimposing two photoacoustic signals having the same frequency and reverse phases to nullify the effect from the other constituent occupying large part of the object to be measured. The constituent concentration measuring apparatus according to the invention includes light generating means for generating two light beams having different wavelengths, modulation means for electrically intensity-modulating each of the two light beams having different wavelengths using signals having the same frequency and reverse phases, light outgoing means for outputting the two intensity-modulated light beams having different wavelengths toward a test subject, and acoustic wave detection means for detecting an acoustic wave generated in the test subject by the outputted light.05-16-2013
20130123591Constituent Concentration Measuring Apparatus and Constituent Concentration Measuring Apparatus Controlling Method - An object of the present invention is to provide a noninvasive constituent concentration measuring apparatus and constituent concentration measuring apparatus controlling method, in which accurate measurement can be performed by superimposing two photoacoustic signals having the same frequency and reverse phases to nullify the effect from the other constituent occupying large part of the object to be measured. The constituent concentration measuring apparatus according to the invention includes light generating means for generating two light beams having different wavelengths, modulation means for electrically intensity-modulating each of the two light beams having different wavelengths using signals having the same frequency and reverse phases, light outgoing means for outputting the two intensity-modulated light beams having different wavelengths toward a test subject, and acoustic wave detection means for detecting an acoustic wave generated in the test subject by the outputted light.05-16-2013
20130217984METHOD AND APPARATUS FOR DETERMINING AN AUTOFLUORESCENCE VALUE OF SKIN TISSUE - A method for determining an autofluorescence value of skin tissue of a subject, comprising the steps of: 08-22-2013
20100222657Method for glucose monitoring using fluorescence quenching - This disclosure relates to systems, devices, and methods of sensing an analyte. An implantable sensor may be contacted with a test sample under conditions that permit a binding protein and a ligand of the sensor to interact in an analyte-dependent manner to produce an analyte-dependent signal, and (b) detecting the analyte-dependent signal with a detector. A binding protein may reversibly bind an analyte and/or a ligand. A binding protein may have a higher binding affinity for an analyte than for a ligand. A binding protein and a ligand may each include a fluorophore, the absorption and/or emission properties of which may change in an analyte-dependent manner. A binding protein and/or a ligand may be bound to an active or inactive substrate. Some embodiments of systems, devices, and methods may be practiced in vitro, in situ, and/or in vivo. Systems and/or devices of the disclosure may be configured to be wearable.09-02-2010
20110028806REFLECTANCE CALIBRATION OF FLUORESCENCE-BASED GLUCOSE MEASUREMENTS - A noninvasive or minimally invasive procedure and system for measuring blood glucose levels is disclosed. A set of photodiodes detects the fluorescence and reflectance of light energy emitted from one or more emitters, such as LEDs, into a patient's skin. In an embodiment, small molecule metabolite reporters (SMMRs) that bind to glucose are introduced to the measurement area to provide more easily detected fluorescence.02-03-2011
20090054748Method and system for providing continuous calibration of implantable analyte sensors - Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.02-26-2009
20090069651MONITORING METHOD AND/OR APPARATUS - A method and apparatus for substance monitoring. One application is an easy to handle continuous glucose monitor using a group of hollow out-of-plane silicon microneedles to sample substances in interstitial fluid from the epidermal skin layer. The glucose of the interstitial fluid permeates a dialysis membrane and reaches a sensor. Using MEMS technology, for example, allows well-established batch fabrication at low cost.03-12-2009
20110009720Continuous whole blood glucose monitor - A portable continuous whole blood glucose monitor comprising, a mid-infrared quantum cascade laser and driver in optical communication with a transmission cell and a photo-conductive detector and pre-amplifier. The monitor further comprises a peristaltic pump connected to a single lumen catheter peripherally inserted into a patient's vein. The single lumen catheter, in combination with the peristaltic pump, is operable to automatically withdraw a fixed and metered amount of whole blood from a patient, then a tube delivers a fixed and metered amount of the saline/surfactant supply to the whole blood. Methods of enhancing measurement sensitivity are also provided.01-13-2011
20100331637Method and System for Measuring a Composition in a Blood Fluid12-30-2010
20110034786PORTABLE HANDHELD MEDICAL DIAGNOSTIC DEVICES - A portable handheld medical diagnostic device includes a front housing and a rear housing opposite the front housing. The front housing and the rear housing form a protective enclosure. A main circuit board is located in the protective enclosure. The main circuit board includes a controller facilitating a physiologic measurement. A display device is connected to the main circuit board that displays information related to the physiologic measurement. A frame is located in the protective enclosure that carries the display device and locates the display device adjacent the front housing such that the display device can be viewed from outside the protective enclosure. The frame includes a strip port formed integrally therewith that is accessible from outside the protective enclosure.02-10-2011
20110137141Wireless Monitoring of Multiple Vital Signs - Devices, systems and methods are presented for monitoring a plurality of vital statistics, sending the statistics over a communications network, and generating real-time feedback for the user. A device includes a microcontroller, a transceiver, a plurality of logic units, a plurality of transducers, and a plurality of sensors. The sensors measure a plurality of vital statistics for a user. Alerts are communicated to the user via a speaker. Audio signals are detected via a microphone and processed by the logic. The transceiver enables wireless communication, directly or across a network. The transceiver further communicates with a wireless communication device. The plurality of health sensors includes a thermometer, a pulse oximeter, and a blood glucose meter.06-09-2011
20110087083ANALYTE MONITORING USING ONE OR MORE ACCELEROMETERS - The present disclosure relates to methods, devices, and systems for measuring a blood analyte, such as glucose. The disclosure relates more specifically to the use in such methods, devices, and systems of one or more accelerometers to aid in the collection of data, operation of the device, filtering, and other uses. In some embodiments, the accelerometers are three-dimensional accelerometers. An accelerometer can be used in conjunction with analyte monitoring that may be performed with infrared, near infrared, or other wavelength spectroscopy. The accelerometer may allow a monitoring instrument to expect noisy measurement data, indicate positioning of a measurement site for improved expected results, indicate position of the instrument, or help the user properly place or control the instrument. It may also improve analyte monitoring by providing motion information that can be used to help determine and reduce or remove movement-related signal artifacts or noise that may be present within the monitoring signal.04-14-2011
20100036215SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20110105867OPTICAL SENSOR FOR DETERMINING THE CONCENTRATION OF AN ANALYTE - A method and apparatus for non-invasively determining a concentration of glucose in a subject using optical excitation and detection is provided. The method includes emitting an exciter beam (B1) to irradiate a portion (05-05-2011
20090048501Glucose measuring device integrated into a holster for a personal area network device - A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.02-19-2009
20090312615Device for Determining the Glucose Level in Body Tissue - The apparatus for the non-invasive glucose detection comprises an electrical detection device (12-17-2009
20100063370Noise tolerant measurement - The invention relates to statistical methods for fitting a mathematical model of the interaction of signals, such as optical signals, with tissue to detected signals or data related to the interaction. In particular it relates to statistical methods for fitting a mathematical model of the interaction of optical signals with tissue to actual signals, such as interferometric signals related to data optical scattering in tissue and their relationship to glucose concentration. It also relates to statistical methods for fitting a mathematical model of the interaction of optical signals with tissue to data such as the spectral distribution values of optical signals absorbed or scattered by tissue and their relationship to glucose concentration. The invention provides a practical non-invasive glucose measurement method and system. The invention also provides a measurement method and system that performs well in low signal-to-noise environments.03-11-2010
20100130839IMPLANTABLE DEVICES AND METHOD FOR DETERMINING A CONCENTRATION OF A SUBSTANCE AND/OR MOLECULE IN BLOOD OR TISSUE OF A PATIENT - In a medical lead having a sensor, an implantable device connectable to such a medical lead and a method for determining the concentration of a substance and/or molecule in blood or tissue of a patient, in particular for determining the concentration of substances and or molecules such as oxygen, carbon dioxide, molecules representative of a PH value, glucose, urea, ammonia, lactose, hormones and insulin, photoluminescent molecules embedded in a carrier, in which the substance and/or molecule to be analyzed diffuse, are excited to emit light by light emitted by a light source of the sensor. The determination of the concentration of the substance and/or molecule is based on the characteristics of the light emitted by the photoluminescent molecules.05-27-2010
20080221415Systems and methods for measuring and improving blood chemistry - Measurement systems provide a determination of relative concentrations of biological analytes based on transmission or reflection of near-infrared radiation by an in vivo specimen. Concentration and concentrations ratios associated with (ω-3, ω-6, and ω-9 fatty acids, lipids, glycosylated proteins, blood glucose, and cholesterol can be determined, and based on the determination an indication of subject health can be provided, or a dietary recommendation can be made. In one example, ratio of a concentration of ω-3 fatty acids to a combined concentration of ω-6 and ω-9 concentrations is determined. Dietary supplements can be recommended or ordered from a supplier based on the concentrations and concentration ratios.09-11-2008
20080319287Implantable Power Sources and Sensors - A protein is provided, including a glucose binding site, cyan fluorescent protein (CFP), and yellow fluorescent protein (YFP). The protein is configured such that binding of glucose to the glucose binding site causes a reduction in a distance between the CFP and the YFP. Substance monitoring apparatus (12-25-2008
20110263954NONINVASIVE BLOOD GLUCOSE METER - A noninvasive blood glucose meter for testing a blood glucose level of a living organism includes a casing, a printed circuit board and a display device. The casing includes a containing space, and the printed circuit board is installed in the containing space and includes a control unit and a memory unit, and the printed circuit board is electrically coupled to a light emitting device and a light receiving device, and the light emitting device is capable of emitting a light beam, and the light receiving device is provided for receiving a reflected light beam. After the light beam emitted from the light emitting device is entered into the testing living organism, reflected from the testing living organism, and received by the light receiving device, the light beam is passed through and processed by the control unit, and then displayed on a display device and stored in the memory unit.10-27-2011
20100324383System for In Vivo Biosensing Based on the Optical Response of Electronic Polymers - A system for continuous in vivo biosensing of specific analyte molecule concentrations based on the dynamic optical properties of electronic polymers is disclosed. The biosensor system includes at least one implant member subcutaneously exposed to the interstitial fluid of the subject, and a reader member at least temporarily positioned over the implant member to probe it with light of specific wavelengths through the skin. The system has many potential applications, including the real-time monitoring of blood glucose levels in diabetics as a method to supplement or replace conventional capillary blood testing.12-23-2010
20100324382CLOSED-LOOP GLUCOSE AND/OR INSULIN CONTROL SYSTEM - Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.12-23-2010
20110190608OPTICAL SENSOR FOR MEDICAL DEVICE - An optical sensor for a medical device includes a fixed lens spacing between emit and receive modules to achieve target sensor sensitivity, while varying other sensor parameters in order to increase signal amplitude without increasing power demand. The size of at least one of emit and receive module lenses of an optical sensor, and the offset between the opto-electronic component and the respective lens of at least one of emit and receive modules is decreased to increase amplitude of the signal received by the receive module from the emit module.08-04-2011
20110190607METHODS AND SYSTEMS TO CORRECT FOR HEMATOCRIT EFFECTS - Described and illustrated herein are exemplary methods of operating an analyte measurement system having a meter and a test strip. Such methods may be exemplarily achieved by determining a first glucose concentration by measuring a first reflectance at about a first wavelength at a testing surface of the pad; measuring a second reflectance at about a second wavelength; formulating at least one equation to correct the first glucose concentration for temperature or hematocrit effects using the second reflectance at about the second wavelength; determining a second glucose concentration using the first glucose concentration, the second reflectance at about a second wavelength; and displaying the second glucose concentration that is corrected for temperature and hematocrit effects.08-04-2011
20110152647DIODE LASER DEVICE FOR THE NON-INVASIVE MEASUREMENT OF GLYCAEMIA - A device has two diode laser sources in a range between 500 and 1000 nm, with a power in the range between 0.01 to 100 mW. Rays from the sources are conveyed through an optical condenser and, starting up a key, are emitted either on a nail or on the skin or even on a free blood sample. A photodiodic sensor or a CPU read the energy subtracted by glycate haemoglobin and free plasmic glucose. This value is converted into the immediate glycaemia value and appears on a device display.06-23-2011
20100030040MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS - The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.02-04-2010
20110118570OPTIC SENSOR DEVICE WITH SERS - The present invention relates to a system for determining a concentration of a substance of interest in a body fluid, more specifically to systems comprising sensor devices for optically detecting compounds such as glucose. The system of the present invention is, e.g., suitable for continuous determination of a concentration of a substance of interest which is present in a body fluid, e.g. a concentration of glucose in blood or interstitial fluid.05-19-2011
20110118571METHOD OF PERFORMING WAVELENGTH MODULATED DIFFERENTIAL LASER PHOTOTHERMAL RADIOMETRY WITH HIGH SENSITIVITY - Methods are provided for the detection of an analyte in a sample using wavelength modulated differential photothermal radiometry with enhanced sensitivity. A wavelength modulated differential photothermal radiometry system, comprising two optical modulated beams, where each beam experiences different absorption by the analyte, is calibrated by controlling the relative phase difference between the modulated beams so that individual photothermal signals corresponding to each modulated beam are 180° out of phase, corresponding to peak sensitivity to analyte concentration. The system may be further calibrated by varying the relative intensities of the two modulated beams and measuring standards containing known analyte concentration in order to determine an optimal relative intensity for a given concentration range of interest.05-19-2011
20100121163Optical Microneedle-Based Spectrometer - Optical microneedles are adapted for near-infrared or mid-infrared in vivo spectroscopic sensing; and provide a MEMS-based spectrometer for continuous lactate and glucose monitoring by means of a near-infrared or mid-infrared optical microneedle array in a transdermal patch.05-13-2010
20100016689METHOD FOR NONINVASIVE MEASUREMENT OF GLUCOSE AND APPARATUS FOR NONINVASIVE MEASUREMENT OF GLUCOSE - A method for noninvasive measurement of glucose in a tissue of a subject, including the steps of bringing an adaptation device, which has a shape similar to a measurement probe, into contact with a skin part of a subject for stretching the skin part of the subject under a pressure that is higher than a pressure per unit area applied by the measurement probe during the noninvasive measurement, maintaining the contact for a predetermined period of time followed by relieving the contact, bringing the measurement probe into contact with the stretched skin part of the subject for the noninvasive measurement, collecting signals emitted from the subject, and estimating a glucose concentration based on the collected signals.01-21-2010
20100160749IMPLANTABLE OPTICAL GLUCOSE SENSING - Apparatus is provided, including a support configured to be implanted within a body of a subject and a sampling region coupled to the support. The apparatus is configured to passively allow passage through the sampling region of at least a portion of fluid from the subject. The apparatus also comprises an optical measuring device in optical communication with the sampling region. The optical measuring device comprises at least one light source configured to transmit light through at least a portion of the fluid, and at least one sensor configured to measure a parameter of the fluid by detecting light passing through the fluid. Other embodiments are also described.06-24-2010
20090247843Method and System for Non-Invasive Blood Glucose Detection Utilizing Spectral Data of One or More Components Other Than Glucose - A method and system for detecting glucose in a biological sample is disclosed. This includes illuminating a biological sample with a light source, collecting transmitted, transflected or reflected light from the sample with a detector, generating spectral data of one or more components in the sample other than glucose in a spectral data analysis device, and analyzing the spectral data of the one or more components, sufficient to provide a glucose measurement from the spectral data of the one or more components other than glucose with the spectral data analysis device.10-01-2009
20110034787Device for Interstitial Fluid Extraction, Production Process Thereof and Analyzing Process of Interstitial Fluid Using the Device - A device for interstitial fluid extraction, having a base material formed from a synthetic resin film, a pressure sensitive adhesive layer, a hydrogel layer formed from at least one hydrophilic polymer selected from the group consisting of polyvinyl alcohol and polyvinyl pyrrolidone, and a release layer, wherein the hydrogel layer has an area of a size that the pressure sensitive adhesive layer is exposed from around the hydrogel layer, does substantially not contain a sodium ion and causes no water separation.02-10-2011
20120016216REAL-TIME MICRODIALYSIS SYSTEM - Microdialysis systems and methods that enable self-diagnostic functions for microdialysis, including continuous monitoring of diffusion, convection, and osmosis, as well as providing intelligent flow rate control, to mitigate variability in analyte recovery. The microdialysis system measures real-time tracer concentration levels in the dialysate and/or real01-19-2012
20120016215SYSTEM AND METHOD FOR DYNAMICALLY ADJUSTING PATIENT THERAPY - A system and method of managing therapy provided to patients in an institution. The system monitors all aspects of the medication delivery to a patient, as well as other information related to the patient, such as values of vital signs, laboratory results and patient factors such as history, diagnosis, allergies and the like. The system includes one or more databases of information, including institutionally developed rules, guidelines and protocol representing the best medical practices of the institution. The system provides alerts and/or recommendations based on the application of the rules to the information being monitored, and alerts care givers accordingly, providing for dynamic adjustment of the patient's therapy. The system also monitors the status of the alerts, and if no action is taken in a selected period of time, may escalate the priority of the alert and/or halt the delivery of medication to the patient until the alert is resolved.01-19-2012
20120016214CALIBRATION METHOD FOR CALIBRATING AN INSTRUMENT FOR MEASURING BIOGENIC SUBSTANCE, USING NEAR-INFRARED SPECTRAL SPECTROSCOPY - A simple calibration method for calibrating an instrument for measuring a biogenic substance, using near-infrared spectral spectroscopy is realized. The calibration method comprises (1) the step of measuring a specific substance of a biological object with the use of an instrument for measuring a biogenic substance, using a confocal optical system, (2) the step of using an instrument for measuring a biogenic substance, using near-infrared spectral spectroscopy, thereby measuring a specific substance in the same region of the biological object, (3) the step of comparing a measured value of the specific substance, measured in the step (1) with a measured value of the specific substance, measured in the step, and (4) the step of executing an operation in the step at least once after the elapse of predetermined time.01-19-2012
20120310056Peritoneal dialysis system - The invention relates to a peritoneal dialysis sampling system to be used together with a peritoneal dialysis system which is programmed to deliver fluid to a peritoneal cavity of a patient and to drain the fluid from the cavity, said peritoneal dialysis system comprising a supplying line and supplying means for supplying dialysis fluid to the peritoneal cavity, a draining line and draining means for draining the fluid from the cavity, said peritoneal dialysis sampling system comprising an automatic sampling system which is able to automatically sample volumic fractions of the dialysate contained in the peritoneum of the patient at specific time intervals in order to evaluate the peritoneal membrane characteristics and/or improve the peritoneal dialysis for a given patient.12-06-2012
20120022347USING MUSCLE TENSION SENSING TO LOCATE AN ANALYTE MEASUREMENT SITE ON THE SKIN - Apparatus for determining where to locate a measuring device (01-26-2012
20120059232IMPLANTABLE OPTICAL GLUCOSE SENSING - Apparatus is provided, including a support (03-08-2012
20120209094MONITORING BLOOD CONSTITUENT LEVELS IN BIOLOGICAL TISSUE - In accordance with the invention, a low coherence interferometer is used to non-invasively monitor the concentration of glucose in blood by shining a light over a surface area of human or animal tissue, continuously scanning the light over a two dimensional area of the surface, collecting the reflected light from within the tissue and constructively interfering this reflected light with light reflected along a reference path to scan the tissue in depth. Since the reflection spectrum is sensitive to glucose concentration at particular wavelengths, measurement and analysis of the reflected light provides a measure of the level of glucose in the blood. The measurement of glucose is taken from multiple depths within blood-profused tissue, and sensitivity is preferably enhanced by the use of multiple wavelengths. Noise or speckle associated with this technique is minimized by continuously scanning the illuminated tissue in area and depth.08-16-2012
20110184259Fiber Optic Device for Sensing Analytes and Method of Making Same - A device for sensing analyte concentration, and in particular glucose concentration, in vivo or in vitro is disclosed. A sensing element is attached to the distal end of an optical conduit, and comprises at least one binding protein adapted to bind with at least one target analyte. The sensing element further comprises at least one reporter group that undergoes a luminescence change with changing analyte concentrations. Optionally, the optical conduit and sensing element may be housed within a cannulated bevel.07-28-2011
20110105866OPTICAL SENSOR CONFIGURATION FOR RATIOMETRIC CORRECTION OF BLOOD GLUCOSE MEASUREMENT - Embodiments of the invention are directed to an optical sensor for detecting blood glucose. The sensor comprises a chemical indicator system disposed within a gap between the distal end of an optical fiber and an atraumatic tip portion, wherein the optical fiber and atraumatic tip portion are coupled by a coupling member, such as a rod or hypotube or cage that traverses the gap. The sensor further comprises a means for generating and detecting an optical reference signal unrelated to the blood glucose, such that ratiometric correction of blood glucose measurements for artifacts in the optical system is enabled.05-05-2011
20090131772MEDICAL DEVICE - A medical device (05-21-2009
20120165626DEVICES, METHODS, AND KITS FOR DETERMINING ANALYTE CONCENTRATIONS - Devices, methods, and kits for measuring or otherwise evaluating the concentration of one or more analytes in a body fluid are described. The devices, methods, and/or kits may be non-invasive. In some variations, a method for measuring the concentration of an analyte in sweat of a subject may comprise contacting a colorimetric membrane with a skin surface of the subject so that the membrane collects a volume of sweat from the skin surface, and analyzing the colorimetric membrane to determine the concentration of the analyte in the collected volume of sweat.06-28-2012
20120165625Device For The Transcutaneous, In Vivo Measurement Of The Concentration Of At Least One Analyte In A Living Organism - The invention relates to a device for the transcutaneous, in vivo measurement of the concentration of at least one analyte in a living organism, comprising a carrier which can be introduced into the organism, and a luminescence indicator which is immobilized on the carrier and which reacts to a change in the concentration of the analyte to be measured with a change in at least one optical property, wherein the luminescence indicator is transcutaneously connected to a source for providing the excitation radiation and a detector for detecting the measuring radiation. According to the invention, the luminescence indicator is immobilized on the outer circumference of a catheter, which is used to dispense a fluid medium, for example a medicament, into the organism or to suck up a body fluid.06-28-2012
20120130209Implantable Sensor Unit - A sensor unit functionally stable in an implant, for performing qualitative and/or quantitative in vivo determination of an analyte, including a connection area (05-24-2012
20120172686NONINVASIVE GLUCOSE SENSING METHODS AND SYSTEMS - New methods and systems for noninvasive glucose monitoring and sensing with electromagnetic waves or ultrasound are disclosed. The methods are based on absolute or relative measurement of tissue dimensions (or changes in the dimensions) including, but not limited to: thickness, length, width, diameter, curvature, roughness as well as time of flight of ultrasound and optical pulses and optical thickness, which change with changing blood glucose concentrations. By measuring noninvasively absolute or relative changes in at least one dimension of at least one tissue or tissue layer or absolute or relative changes in time of flight of ultrasound or optical pulses, one can monitor blood glucose concentration noninvasively.07-05-2012
20100174159NON-INVASIVE BODY INFORMATION MEASUREMENT APPARATUS - A non-invasive body information measurement apparatus, in which a blood glucose level is corrected using a blood glucose level measured with an invasive blood glucose measurement apparatus, wherein in a calibration period, measurement of body information is performed at a plurality of luminous energy levels, a plurality of estimated blood glucose levels are calculated from a plurality of characteristic quantities calculated at the various luminous energy levels and from blood glucose levels measured with an invasive blood glucose measurement apparatus, and at the end of the calibration period, the blood glucose levels measured with the invasive blood glucose measurement apparatus are compared with a plurality of estimated blood glucose levels, and in a normal measurement period a light source is controlled so that measurement is performed at a luminous energy level corresponding to the estimated blood glucose level that satisfies the targeted accuracy.07-08-2010
20130172699ANALYTE SENSOR WITH EXTENDED RANGE OF DETECTION - Embodiments provide sensors, such as implantable sensors, and methods of producing such sensors. An implantable sensor may include a base, one or more chambers, and one or more sensor reagents. A membrane may be coupled to the chambers over the sensor reagents. The implantable sensor may be at least partially implanted into the dermis of an animal. One or more of the sensor reagents may emit light or exhibit a color change in response to the presence of a target analyte or reaction product thereof. The response may be detected and analyzed by the user or by a reader device to determine the target analyte concentration.07-04-2013
20120215078METHOD FOR MEASURING A CONCENTRATION OF A BIOGENIC SUBSTANCE CONTAINED IN A LIVING BODY - One of the purposes of the present invention is to provide a biogenic substance concentration measuring method with improved measuring accuracy. An embodiment of the present invention provides a method for measuring a concentration of a biogenic substance contained in a living body, the method comprises steps of preparing a measuring device, wherein the measuring device comprises a light source, an optical filter, and a light receiver; irradiating a substantially-parallel light from the light source onto a particle chip implanted in a skin though a position on the surface of the skin to generate a reflected light; inclining the light source and calculating the concentration of the biogenic substance on the basis of the difference of signals before and after the inclination.08-23-2012
20110190609OPTICAL SENSOR FOR MEDICAL DEVICE - An optical sensor for a medical device includes a fixed lens spacing between emit and receive modules to achieve target sensor sensitivity, while varying other sensor parameters in order to increase signal amplitude without increasing power demand. An optical sensor connected to a housing of a medical device includes a circuit board, an opto-electronic component, a wall, a lens, and a ferrule. The circuit board is arranged within the housing. The opto-electronic component is mounted on a surface of the circuit board. The wall protrudes from the surface of the circuit board and surrounds the opto-electronic component. The lens is offset from the surface of the circuit board. The ferrule is connected to the housing, the lens and the wall. An inner surface of the wall mates with an outer surface of the ferrule.08-04-2011
20100298674PROTECTIVE SHELL FOR AN IN VIVO SENSOR MADE FROM RESORBABLE POLYMER - An implantable device with in vivo functionality, where the functionality of the device is negatively affected by the inflammation reaction generally associated with tissue injury, encapsulated by a protective coating that prevents damage to the device from any inflammation reactions. The protective coating is designed to persist for a set period of time, generally until after the inflammation reaction of the surrounding in vivo environment in response to the injury caused by the implantation procedure has concluded. The protective coating is further designed to “resorb” (i.e. to dissociate from the device, dissolve, and be absorbed into the surrounding environment) after a set period of time, allowing the device to perform its in vivo functionality unhindered without loss of performance.11-25-2010
20100298673METHOD FOR THE GLUCOSE CONCENTRATION IN PULSATIONAL BLOOD - Method for the continuous measurement of the glucose concentration in blood undergoing pulsational flow, with the steps: determination of a value for the glucose concentration for a first measurement cycle, and repetition of the determination of this value in subsequent measurement cycles, where there is multiple detection, within each measurement cycle, of the transmittance and/or scattering power of the blood for at least two incident MR wavelengths, calculation of an indicator value depending on the blood glucose concentration, and ascertaining the blood glucose concentration by comparing the indicator value with a previously determined calibration table, determination of the blood temperature during the detection of the transmittance and/or scattering power, continuous measurement of the pulse duration of the pulsational blood flow, where the duration of the measurement cycle is arranged to keep in step as integral multiple of the pulse duration, where the first of the at least two MR wavelengths is selected from the wavelength range 1560-1630 nm, and the second of the at least two MR wavelengths is selected from the wavelength range 790-815 nm, and the ratio of the transmittance and/or scattering power of the at least two wavelengths is calculated, this ratio serving in relation to the blood temperature as indicator value for reading off the blood glucose concentration from the calibration table.11-25-2010
20100274110OPTICAL DETERMINATION OF PH AND GLUCOSE - Embodiments of the present invention are directed to an optical sensor capable of measuring two analytes simultaneously with a single indicator system. In preferred embodiments, the sensor comprises a fluorescent dye having acid and base forms that facilitate ratiometric pH sensing, wherein the dye is further associated with a glucose binding moiety and configured to generate a signal that varies in intensity with the concentration of glucose.10-28-2010
20100022860NON-INVASIVE METHODS OF USING SPECTRAL INFORMATION IN DETERMINING ANALYTE CONCENTRATIONS - A non-invasive method of determining the concentration of an analyte uses Raman or fluorescence spectral information. A high-intensity band of light is applied to one side of skin tissue. The high-intensity light enters the skin tissue and generates a Raman or fluorescence signal. A Raman-generating material or fluorescence-generating material is placed in a location nearest the other side of skin tissue. The Raman-generating or fluorescence-generating material is located generally opposite of the entry of the applied high-intensity light. The Raman or fluorescence signal is collected and the analyte concentration is determined using the collected Raman signal.01-28-2010
20120226118IMPLANTABLE SENSOR - A sensor is described for sensing a substance such as for example glucose. The sensor is implantable in the body of a living creature. The sensor comprises a photonic integrated circuit, e.g. silicon-photonics, based radiation processor for spectrally processing radiation interacting with the sample. A continuous monitoring system also is described using such a sensor.09-06-2012
20120226117HANDHELD PROCESSING DEVICE INCLUDING MEDICAL APPLICATIONS FOR MINIMALLY AND NON INVASIVE GLUCOSE MEASUREMENTS - The present disclosure includes a handheld processing device including medical applications for minimally and noninvasive glucose measurements. In an embodiment, the device creates a patient specific calibration using a measurement protocol of minimally invasive measurements and noninvasive measurements, eventually creating a patient specific noninvasive glucometer. Additionally, embodiments of the present disclosure provide for the processing device to execute medical applications and non-medical applications.09-06-2012
20090018417APPARATUS MONITORING SIGNAL IN SITU - For repeatedly measuring signals from a fixed position of a tissue to monitor the blood composition, we use one or more elastic membranes at upper and lower parts of the extruded tissue together with a cone-shaped guide. This will constrain the tissue in the fixed position when a signal guide is used for measuring signals from the fixed position of the tissue repeatedly. The signals can be from an aggregate of the designated composition with the other ingredients of the blood.01-15-2009
20090018416Analyte Concentration Measurement Device - A method for measuring concentration of an analyte in body fluid comprises acquiring a body fluid sample, emitting light into the body fluid sample, and detecting emitted light intensity on a plurality of optical paths through the body fluid sample. A plurality of optical filters are arranged in respective optical paths of the optical path plurality comprising at least a first optical filter with light absorption by an analyte and water and a second optical filter with light absorption to water alone. Light intensity passed through the first optical filter and passed through the second optical filter is measured and analyte concentration is determined based on a ratio of intensities detected at a detector in an optical path intersected by the first optical filter and detected at a detector in an optical path intersected by the second optical filter.01-15-2009
20110004080METHOD FOR NON-INVASIVE ANALYSIS OF A SUBSTANCE CONCENTRATION WITHIN A BODY - Embodiments of the present methods measure a concentration of a substance, such as glucose, in a body. The described embodiments change the temperature of the surface of a body from a first temperature to a second temperature, then change the temperature of the surface of the body from the second temperature back to the first temperature, and measure a first amount of infrared (“IR”) radiation absorbed or emitted from the surface of the body in a first wavelength band, and a second amount of IR radiation absorbed or emitted from the surface of the body in a second wavelength band at predetermined time intervals during the time period that the temperature of the surface of the body changes from the second temperature back to the first temperature. The described embodiments also measure a temperature at the surface of the body and an ambient temperature. A normalized ratio parameter is calculated from the four measurements, and the concentration of the substance in the body is determined by correlating the normalized ration parameter with the body surface temperature and the ambient temperature.01-06-2011
20120265038METHOD FOR MEASURING A CONCENTRATION OF A BIOGENIC SUBSTANCE CONTAINED IN A LIVING BODY - One of the purposes of the present invention is to provide a biogenic substance concentration measuring method with improved measuring accuracy. An embodiment of the present invention provides a method for measuring a concentration of a biogenic substance contained in a living body, the method comprises steps of preparing a measuring device, wherein the measuring device comprises a light source, an optical filter, and a light receiver; irradiating different focused lights from the light source onto a particle chip implanted in a skin though a position on the surface of the skin to generate corresponding reflected lights; calculating the concentration of the biogenic substance on the basis of the difference of signals obtained from the reflected lights.10-18-2012
20120323094CONTINUOUS MONITORING OF GLUCOSE AND OTHER LIVING BODY CONSTITUENTS - Methods and apparatuses for monitoring the level of glucose or other constituents in live subjects are disclosed. Stem cells are obtained from the subject and processed into cells that change their optical characteristics in response to a level of the constituent. The responsive cells are formed into clusters and implanted into in the subject's body at locations that permit optical monitoring from outside the subject's body. The implanted cell clusters are illuminated and the reflected illumination from each of the cell clusters is detected. Changes in the optical characteristics of the cell clusters that correspond to the responses of the cell clusters are identified, and the identified changes are mapped to a constituent level based on calibration data for each cell cluster. An indication of the constituent level in the subject is then output.12-20-2012
20090088615Indwelling Fiber Optic Probe for Blood Glucose Measurements - An indwelling fiber optic probe can be used to make in vivo blood glucose measurements through a central venous catheter. The fiber optic probe can operate in the near-infrared spectral region. The optical measurement can be backscattering, transmission, or a combination of both, depending on the optical configuration.04-02-2009
20120323093Article and Method for Applying a Coupling Agent for a Non-Invasive Optical Probe - An article of manufacture and method for controlling the application of a coupling agent, such as a silicone oil or mineral oil, on a surface of a tissue prior to contacting the tissue with an apparatus for non-invasive optical measurement of the concentration of an analyte. The article ensures that a specific quantity of the coupling agent is deposited in a uniform layer over the entire target area of the tissue, thereby enhancing both the optical signal and the repeatability of thermal and optical coupling with the components of the apparatus.12-20-2012
20120277554APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE - A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor.11-01-2012
20120101347CONCENTRATION DETERMINATION APPARATUS, CONCENTRATION DETERMINATION METHOD, AND PROGRAM - A concentration determination apparatus may include: an irradiation unit that irradiates short-pulsed light to an observed object; a light receiving unit that receives light backscattered from the observed object; a light intensity acquisition unit that acquires an intensity distribution of the light; an optical path length distribution storage unit that stores a model of an optical path length distribution in each layer of the plurality of layers of the short-pulsed light; an optical path length acquisition unit that acquires the optical path length distribution of each layer; a time-resolved waveform storage unit that stores a model of a time-resolved waveform; a light intensity model acquisition unit that acquires a light intensity model; an integral interval calculation unit that calculates a time range of an area; an optical absorption coefficient calculation and acquisition unit that calculates and acquires an optical absorption coefficient; and a concentration calculation unit that calculates the concentration.04-26-2012
20120289797PHYSIOLOGICAL TREND MONITOR - A physiological trend monitor has a sensor signal responsive to multiple wavelengths of light transmitted into a tissue site. The transmitted light is detected after attenuation by pulsatile blood flow within the tissue site. A processor has an input responsive to the sensor signal and a physiological parameter output. Features are extracted from the physiological parameter output. Criteria are applied to the features. An alarm output is generated when the criteria are satisfied.11-15-2012
20120289796Noninvasive, Accurate Glucose Monitoring with OCT By Using Tissue Warming and Temperature Control - A new OCT system and method are disclosed, where the system includes a probe equipped with a heating element and a high heat conductive member to warm a tissue site to be scanned to an elevated and/or to maintain the elevated tissue temperature with a temperature variation of less than or equal to 1° C. to improve an accuracy and reliability of an OCT glucose concentration value other long measurement durations. The new OCT system and method can also be equipped with pressure components to reduce a pressure exerted on the tissue site to a minimal constant pressure.11-15-2012
20120150001Hyaluronic acid based glucose monitoring - The invention provides a method for using OCT human tissue scan data for tracking a scan structure in depth, follow change in structure position within an OCT scan from, for example, fasting glucose level to peak glucose level and back down again, and relate the structure position change to analyte concentration. In the preferred embodiment, the analyte of interest is glucose concentration and the target of interest is living human skin. A hyaluronic acid based mechanism is suggested for dermis thickness. Alternate embodiments of the method are presented, including curve fitting of topographic regions corresponding to trackable target features.06-14-2012
20130018238Enhanced non-invasive analysis system and method - The invention provides an enhanced method and system for non-invasive analysis of a target. The enhancement includes increased analytic power derived from creating a complete representation of a target using less than complete information. The invention provides a non-invasive analysis system and method that includes generating and exploiting a system model that includes a target model that accurately represents the interaction of radiant energy with a target.01-17-2013
20080228051ANALYTE MEASURING DEVICE - An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.09-18-2008
20080228050Noninvasive in vivo measuring system and noninvasive in vivo measuring method by correcting influence of Hemoglobin - A noninvasive in vivo measuring system and a noninvasive in vivo measuring method are provided. In the noninvasive in vivo measuring system, a Raman-fluorescence measuring unit measures blood sugar concentration, which is measured using Raman spectra before and after applying a pressure on a finger, and outputs a final blood sugar level by correcting the blood sugar concentration measurement according to a Hemoglobin (Hb) concentration measured by an Hb measuring unit.09-18-2008
20130172698DEVICES AND METHODS FOR BODY FLUID SAMPLING AND ANALYSIS - Described here are meters and methods for sampling, transporting, and/or analyzing a fluid sample. The meters may include a meter housing and a cartridge. In some instances, the meter may include a tower which may engage one or more portions of a cartridge. The meter housing may include an imaging system, which may or may not be included in the tower. The cartridge may include one or more sampling arrangements, which may be configured to collect a fluid sample from a sampling site. A sampling arrangement may include a skin-penetration member, a hub, and a quantification member.07-04-2013
20130178723NON-INVASIVE OPTICAL DETECTION OF BLOOD GLUCOSE BASED ON PHASE MASKS - Non-invasive [blood] glucose testing devices and testing methods without using a blood sample are disclosed and can be used for optically interrogating substances overlaid by turbid media based on wavefront manipulation by means of binary phase masking. Through altering the degree of mode conformity between the fields reaching the collection optics and the field distributions of the propagation modes of optical waveguides the disclosed method can be used to suppress the collection of short-range light originated near the collection optics while permitting unimpeded collection of light originated from sites substantially behind turbid media.07-11-2013
20130178724APPARATUS AND METHOD FOR PREDICTING A PARAMETER IN THE BLOOD STREAM OF A SUBJECT - An apparatus and method for predicting a parameter in the blood stream of a subject is disclosed. The apparatus includes a laser diode source arranged to emit light of at least two different wavelengths; a first optical receiver arranged to receive incident light of the two different wavelengths where the subject is not present; a second optical receiver arranged to receive transmitted or diffuse reflected light of the two different wavelengths when a desired part of the subject is present and a processor for calculating the ratio of the intensity of the received transmitted or diffuse reflected light to incident light for each of the at least two different wavelengths to provide an indication of the parameter in the blood stream of the subject. The apparatus and method are particularly suited for measuring HbA1c in an individual.07-11-2013
20130158373SYSTEM FOR WITHDRAWING SMALL AMOUNTS OF BODY FLUID - A system is provided for withdrawing small amounts of body fluid from an animal or human. The system includes a holder and a disposable lancing unit attached to the holder. The lancing unit also includes an open capillary channel for transporting the body fluid and piercing the skin.06-20-2013
20080200781Glucose Sensor - A system for the non-invasive measurement of glucose concentration in a live subject is disclosed. The system exploits the metabolic heat conformation method, and comprises temperature sensing means for measuring the body heat in respect of the subject and means for measuring the concentration of haemoglobin and oxygenated haemoglobin in the blood of the subject. The system further comprises irradiating means for irradiating a portion of the live subject, a detector for collecting the measuring beam reflected by the live subject, means for determining from the reflected measuring beam, the blood flow velocity in respect of the live subject, and means for determining glucose concentration in the live subject as a function of the body heat, the haemoglobin and oxygenated haemoglobin concentrations and the blood flow velocity.08-21-2008
20120283531Determination of a Measure of a Glycation End-Product or Disease State Using Tissue Fluorescence Lifetime - The present invention provides methods and apparatuses for determining a measure of a tissue state in an individual. Light emitted by tissue of the individual due to fluorescence of a chemical with the tissue detected. The invention can comprise measuring the fluorescence lifetime in either time-domain or frequency domain modes. The invention can also comprise a variety of models relating fluorescence to a measure of tissue state, for example, multivariate models can be developed that relate lifetime trends of one or more constituents to increasing propensity to diabetes and pre-diabetes. Other biologic information can be used in combination with the fluorescence properties to aid in the determination of a measure of tissue state.11-08-2012
20120283530METHOD AND APPARATUS TO DETECT CORONARY ARTERY CALCIFICATION OR DISEASE - Coronary artery calcification (CAC) occurs at an earlier age in diabetes and is a risk factor for coronary artery disease (CAD) in subjects with or without diabetes. One postulated mechanism for the increased CAC is the accelerated accumulation of advanced glycation end products (AGEs) in the vasculature. As certain collagen AGEs fluoresce, skin intrinsic fluorescence (SIF) can act as a novel maker of collagen AGEs levels. The present invention provides methods and apparatuses for detecting SIF that can be a useful marker of CAD risk and a therapeutic target.11-08-2012
20120029328FLUORESCENCE SENSOR, NEEDLE-TYPE FLUORESCENCE SENSOR, AND METHOD FOR MEASURING ANALYTE - A needle-type fluorescence sensor that measures glucose based on fluorescence produced by excitation light is provided. The needle-type fluorescence sensor includes a needle body section including a sensor portion disposed in a needle distal end portion and metal lines disposed from the sensor portion to a needle proximal end portion, and a connector which is integrated with the needle body section and in which the metal lines extend. The sensor portion includes a silicon substrate having first and second principal surfaces, a PD device that converts fluorescence into an electric signal, an LED device that transmits fluorescence and emits excitation light, and an indicator layer that interacts with an analyte under the excitation light to produce fluorescence. The PD device, the LED device, and the indicator layer overlap with each other above the first principal surface of the silicon substrate.02-02-2012
20120029327Controlling Diabetes with a Cellular GPRS-Linked Glucometer-Pedometer - The Cellular GPRS system includes a cellular-based Glucometer (CBG) for blood glucose monitoring, a pedometer for exertion measurement, combined with user-entered dietary or other diabetes-relevant information. Data from all inputs is transmitted over a cellular network, using a GPRS or other wireless link. The data is preferably stored in the device prior to being transmitted wirelessly over the cellular airway to a central computer server. The remote computer server will evaluate the data received and respond with a data packet (making recommendations on further glucose measurement, exercise, diet, insulin requirements or other).02-02-2012
20130211213DIGITAL ASIC SENSOR PLATFORM - The present invention relates to an optical sensor that may be implanted within a living animal (e.g., a human) and may be used to measure the concentration of an analyte in a medium within the animal. The optical sensor may wirelessly receive and may be capable of bi-directional data communication. The optical sensor may include a semiconductor substrate in which various circuit components, one or more photodectors and/or a light source may be fabricated. The circuit components fabricated in the semiconductor substrate may include a comparator, an analog to digital converter, a temperature transducer, a measurement controller, a rectifier and/or a nonvolatile storage medium. The comparator may output a signal indicative of the difference between the outputs of first and second photodetectors. The measurement controller may receive digitized temperature, photodetector and/or comparator measurements and generate measurement information, which may be wirelessly transmitted from the optical sensor.08-15-2013
20130211212DETERMINING THE BLOOD SUGAR LEVEL IN A PATIENT BY USING AN IMPLANTABLE SENSOR AND AN ELECTRICAL FUNCTIONAL ADHESIVE BANDAGE - An implantable sensor includes a hydrogel, a glucose-binding protein and a reference molecule. The binding affinity of the reference molecule for glucose differs by at least a factor of ten from the binding affinity for glucose of the glucose-binding protein. At least one of the electromagnetic behavior and the fluorescent behavior of the glucose-binding protein and the reference molecule change when glucose is bound. An electrical functional adhesive bandage includes a measurement element for measuring at least one of electromagnetic properties and fluorescent properties. The bandage also includes a first communication element for wireless communication. Together, the implantable sensor, the bandage, and an evaluation device, which includes a computation unit, a display and a second communication element for wireless communication, form a kit for determining the blood sugar level in a patient.08-15-2013
20130211214CONFIGURABLE PATIENT MONITORING SYSTEM - A patient monitoring system can display one or more configurable health monitors on a configurable user interface. The health indicators are configured to display a physiological signal from a patient. The patient monitoring system can calculate ranges of values for the health indicator that correspond to a status of the patient. The health indicators can display different outputs based on the value of the physiological signal.08-15-2013

Patent applications in class Glucose